Skip to main content
. 2020 May 20;18(2):1559325820926765. doi: 10.1177/1559325820926765

Figure 1.

Figure 1.

Gestational diabetes mellitus (GDM) symptoms were relieved by astaxanthin (AX) administration. A, Maternal body weight was recorded on gestation day (GD) 0, 9, and 18 in wild-type group, GDM group, and GDM + AX group (AX doses: 10, 25, or 40 mg/kg). B, Body weight changes from GD 0 to GD 18 were calculated. C, Serum glucose of each group was measured on GD 0, 9, and 18. D, The efficacy of AX in the maintenance of insulin levels. n = 12 for each group. Data were presented as means ± standard error of mean (SEM). # P < .05, ## P < .01, ### P < .001 compared to the wild-type group. *P < .05, **P < .01 between the comparison of GDM group and GDM + AX group. &P < .05 between the indicated groups.